Early "reduction to practice" of the CRISPR-Cas9 invention in eukaryotic cells

Front Genet. 2022 Oct 4:13:1009688. doi: 10.3389/fgene.2022.1009688. eCollection 2022.
No abstract available

Keywords: Broad Institute; CRISPR-Cas9 applications; CVC; inventive step; reduction to practice; substancial evidence.